Imran Vhora

Title: Imran Vhora: Innovator in Ocular Inflammation Treatment

Introduction

Imran Vhora is a notable inventor based in Tallahassee, FL (US). He has made significant contributions to the field of ocular health through his innovative research and patent work. His dedication to improving treatment options for ocular inflammation has positioned him as a key figure in this area of study.

Latest Patents

Imran Vhora holds a patent for "Targeted carriers for tacrolimus for ocular inflammation." This formulation and method aim to treat or reduce ocular surface inflammation and associated diseases and disorders. The innovative formulation includes targeted micelles that encapsulate tacrolimus within a pharmaceutically acceptable carrier, which is further coated in arginine-glycine-aspartic acid peptide. This advancement represents a significant step forward in the treatment of ocular conditions.

Career Highlights

Imran Vhora is affiliated with Florida A&M University, where he continues to engage in research and development in the field of ocular health. His work not only contributes to academic knowledge but also has practical implications for patient care and treatment methodologies.

Collaborations

Imran collaborates with esteemed colleagues such as Mandip Singh Sachdeva and Shallu Kutlehria. These partnerships enhance the research environment and foster innovation in their shared field of study.

Conclusion

Imran Vhora's contributions to ocular inflammation treatment through his patented formulation highlight his role as an innovator in the medical field. His work at Florida A&M University and collaborations with fellow researchers further underscore his commitment to advancing healthcare solutions.